Media Summary: Dr. Atish Choudhury is the Co-Director of the A recently FDA-approved treatment, Lutetium-PSMA (LUPsma), provides a new Erica Mayer, MD, MPH, and Nancy Lin, MD, advise patients on how to know which

How Are Clinical Trials Used In Prostate Cancer Dana Farber Cancer Institute - Detailed Analysis & Overview

Dr. Atish Choudhury is the Co-Director of the A recently FDA-approved treatment, Lutetium-PSMA (LUPsma), provides a new Erica Mayer, MD, MPH, and Nancy Lin, MD, advise patients on how to know which The Lank Center for Genitourinary Oncology at

Photo Gallery

How are Clinical Trials Used in Prostate Cancer? | Dana-Farber Cancer Institute
Dana-Farber Research: Treatment resistance in prostate cancer
What is it like to participate in a clinical trial? | Dana-Farber Cancer Institute
Provenge prostate cancer vaccine - Dana-Farber Cancer Institute
Prostate cancer screening and treatment | Dana-Farber Cancer Institute
What's Next for Prostate Cancer Research? | Dana-Farber Cancer Institute
Prostate cancer research advances | Dana-Farber Cancer Institute
What's New in Prostate Cancer Treatment? | Dana-Farber Cancer Institute
When Should Prostate Cancer Patients Consider a Clinical Trial?
Improving access to blood cancer clinical trials | Dana-Farber Cancer Institute
Prostate Cancer Research: Mapping the patient journey | Dana-Farber Cancer Institute
Prostate Cancer: New treatment offers hope | Dana-Farber Cancer Institute
Sponsored
Sponsored
View Detailed Profile
How are Clinical Trials Used in Prostate Cancer? | Dana-Farber Cancer Institute

How are Clinical Trials Used in Prostate Cancer? | Dana-Farber Cancer Institute

Mark Pomerantz, MD, of

Dana-Farber Research: Treatment resistance in prostate cancer

Dana-Farber Research: Treatment resistance in prostate cancer

Prostate Cancer Research

Sponsored
What is it like to participate in a clinical trial? | Dana-Farber Cancer Institute

What is it like to participate in a clinical trial? | Dana-Farber Cancer Institute

Julia Rotow, MD,

Provenge prostate cancer vaccine - Dana-Farber Cancer Institute

Provenge prostate cancer vaccine - Dana-Farber Cancer Institute

Philip Kantoff, MD, explains why the

Prostate cancer screening and treatment | Dana-Farber Cancer Institute

Prostate cancer screening and treatment | Dana-Farber Cancer Institute

Dr. Philip Kantoff, director of

Sponsored
What's Next for Prostate Cancer Research? | Dana-Farber Cancer Institute

What's Next for Prostate Cancer Research? | Dana-Farber Cancer Institute

Mark Pomerantz, MD, of

Prostate cancer research advances | Dana-Farber Cancer Institute

Prostate cancer research advances | Dana-Farber Cancer Institute

Prostate cancer

What's New in Prostate Cancer Treatment? | Dana-Farber Cancer Institute

What's New in Prostate Cancer Treatment? | Dana-Farber Cancer Institute

Mark Pomerantz, MD, of

When Should Prostate Cancer Patients Consider a Clinical Trial?

When Should Prostate Cancer Patients Consider a Clinical Trial?

Dr. Atish Choudhury is the Co-Director of the

Improving access to blood cancer clinical trials | Dana-Farber Cancer Institute

Improving access to blood cancer clinical trials | Dana-Farber Cancer Institute

The Blood

Prostate Cancer Research: Mapping the patient journey | Dana-Farber Cancer Institute

Prostate Cancer Research: Mapping the patient journey | Dana-Farber Cancer Institute

Dana

Prostate Cancer: New treatment offers hope | Dana-Farber Cancer Institute

Prostate Cancer: New treatment offers hope | Dana-Farber Cancer Institute

A recently FDA-approved treatment, Lutetium-PSMA (LUPsma), provides a new

How is Prostate Cancer Treated? | Dana-Farber Cancer Institute

How is Prostate Cancer Treated? | Dana-Farber Cancer Institute

Mark Pomerantz, MD, of

Prostate Cancer: Radiopharmaceutical treatment option | Dana-Farber Cancer Institute

Prostate Cancer: Radiopharmaceutical treatment option | Dana-Farber Cancer Institute

Targeting

Considering Clinical Trials for Prostate Cancer? Key Questions to Ask

Considering Clinical Trials for Prostate Cancer? Key Questions to Ask

What are

Prostate cancer on the rise | Dana-Farber Cancer Institute

Prostate cancer on the rise | Dana-Farber Cancer Institute

Prostate cancer

Prostate Cancer Research: Is there a future for immunotherapy?

Prostate Cancer Research: Is there a future for immunotherapy?

Dana

How to Know Which Clinical Trail is Right

How to Know Which Clinical Trail is Right

Erica Mayer, MD, MPH, and Nancy Lin, MD, advise patients on how to know which

2025 ESMO Prostate Cancer Highlights

2025 ESMO Prostate Cancer Highlights

The Lank Center for Genitourinary Oncology at